Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?

To: James Reynolds who wrote (2)	2/3/1998 11:20:00 AM
From: IMW	Read Replies (1) \| Respond to of 447

IMO, when the next patent is announced, yesterday will have been a great buying opportunity.

To: James Reynolds who wrote (2)	3/29/1998 2:15:00 AM
From: 777 Captain	Read Replies (1) \| Respond to of 447

Have been following for about two months now. Sold my position in PRX today, impressed with that company's persistency. Anyway, OSPI doesn't look bad, probably further along than when I bought PRX, which was at about 2/share when purchased. Have some more homework to do on this one - but if it looks tempting, I'll probably be jumping in. If you have already invested, what has been your experience with the company, e.g., "straight shooters," or otherwise. Also, any of you investors out there, especially any shorts (at this level?), please tell me why you have decided to go long or short. Would really like to have any decision to buy this stock "taken apart."